These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 17166884

  • 21. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J.
    Cancer Lett; 2005 Sep 28; 227(2):105-14. PubMed ID: 16112413
    [Abstract] [Full Text] [Related]

  • 22. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
    Lu PH, Wei MX, Si SP, Liu X, Shen W, Tao GQ, Chen MB.
    Breast Cancer Res Treat; 2011 Feb 28; 126(1):141-8. PubMed ID: 20665102
    [Abstract] [Full Text] [Related]

  • 23. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer.
    Bebb DG, Yu Z, Chen J, Telatar M, Gelmon K, Phillips N, Gatti RA, Glickman BW.
    Br J Cancer; 1999 Aug 28; 80(12):1979-81. PubMed ID: 10471049
    [Abstract] [Full Text] [Related]

  • 24. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP, Bendix R, Chen P, Clark R, Dork T, Lavin MF.
    Proc Natl Acad Sci U S A; 2002 Jan 22; 99(2):925-30. PubMed ID: 11805335
    [Abstract] [Full Text] [Related]

  • 25. ATM c.7570G>C is a high-risk allele for breast cancer.
    Kankuri-Tammilehto M, Tervasmäki A, Kraatari-Tiri M, Rahikkala E, Pylkäs K, Kuismin O.
    Int J Cancer; 2023 Feb 01; 152(3):429-435. PubMed ID: 36161273
    [Abstract] [Full Text] [Related]

  • 26. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
    Tapia T, Sanchez A, Vallejos M, Alvarez C, Moraga M, Smalley S, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2008 Jan 01; 107(2):281-8. PubMed ID: 17351744
    [Abstract] [Full Text] [Related]

  • 27. Founder effects for ATM gene mutations in Italian Ataxia Telangiectasia families.
    Chessa L, Piane M, Magliozzi M, Torrente I, Savio C, Lulli P, De Luca A, Dallapiccola B.
    Ann Hum Genet; 2009 Sep 01; 73(Pt 5):532-9. PubMed ID: 19691550
    [Abstract] [Full Text] [Related]

  • 28. ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia.
    Birrell GW, Kneebone K, Nefedov M, Nefedova E, Jartsev MN, Mitsui M, Gatti RA, Lavin MF.
    Hum Mutat; 2005 Jun 01; 25(6):593. PubMed ID: 15880721
    [Abstract] [Full Text] [Related]

  • 29. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
    Vorechovský I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster AD, Yuille MA.
    Nat Genet; 1997 Sep 01; 17(1):96-9. PubMed ID: 9288106
    [Abstract] [Full Text] [Related]

  • 30. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
    Bay JO, Uhrhammer N, Pernin D, Presneau N, Tchirkov A, Vuillaume M, Laplace V, Grancho M, Verrelle P, Hall J, Bignon YJ.
    Hum Mutat; 1999 Sep 01; 14(6):485-92. PubMed ID: 10571946
    [Abstract] [Full Text] [Related]

  • 31. [Role of the ATM gene in genetic predisposition to cancer].
    Bay JO, Uhrhammer N, Stoppa-Lyonnet D, Hall J.
    Bull Cancer; 2000 Jan 01; 87(1):29-34. PubMed ID: 10673629
    [No Abstract] [Full Text] [Related]

  • 32. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 01; 14(4):821-5. PubMed ID: 15824150
    [Abstract] [Full Text] [Related]

  • 33. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children.
    Liberzon E, Avigad S, Stark B, Zilberstein J, Freedman L, Gorfine M, Gavriel H, Cohen IJ, Goshen Y, Yaniv I, Zaizov R.
    Genes Chromosomes Cancer; 2004 Feb 01; 39(2):161-6. PubMed ID: 14695997
    [Abstract] [Full Text] [Related]

  • 34. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
    Zhang N, Che J, Bai S, Wu Z, Cui Y, Zou W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan 01; 26(1):9-15. PubMed ID: 20353086
    [Abstract] [Full Text] [Related]

  • 35. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
    Gutiérrez-Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J.
    Genes Chromosomes Cancer; 2004 Jun 01; 40(2):109-19. PubMed ID: 15101044
    [Abstract] [Full Text] [Related]

  • 36. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
    Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N.
    Nat Genet; 2006 Aug 01; 38(8):873-5. PubMed ID: 16832357
    [Abstract] [Full Text] [Related]

  • 37. Cancer risks and mortality in heterozygous ATM mutation carriers.
    Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF.
    J Natl Cancer Inst; 2005 Jun 01; 97(11):813-22. PubMed ID: 15928302
    [Abstract] [Full Text] [Related]

  • 38. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK.
    Cancer Res; 2000 Jun 15; 60(12):3299-304. PubMed ID: 10866324
    [Abstract] [Full Text] [Related]

  • 39. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
    Umesako S, Fujisawa K, Iiga S, Mori N, Takahashi M, Hong DP, Song CW, Haga S, Imai S, Niwa O, Okumoto M.
    Breast Cancer Res; 2005 Jun 15; 7(1):R164-70. PubMed ID: 15642165
    [Abstract] [Full Text] [Related]

  • 40. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
    Waddell N, Jonnalagadda J, Marsh A, Grist S, Jenkins M, Hobson K, Taylor M, Lindeman GJ, Tavtigian SV, Suthers G, Goldgar D, Oefner PJ, kConFab Investigators, Taylor D, Grimmond S, Khanna KK, Chenevix-Trench G.
    Genes Chromosomes Cancer; 2006 Dec 15; 45(12):1169-81. PubMed ID: 17001622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.